These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 21177311)

  • 1. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation.
    Genro VK; Grynberg M; Scheffer JB; Roux I; Frydman R; Fanchin R
    Hum Reprod; 2011 Mar; 26(3):671-7. PubMed ID: 21177311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evidence of follicle responsiveness to FSH by antimüllerian hormone in ovulating women].
    Scheffer JB; Lozano DM; Frydman R; Bussab A; Taieb J; Fanchin R
    Rev Bras Ginecol Obstet; 2009 Mar; 31(3):142-7. PubMed ID: 19547890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The follicular output rate in normo-ovulating women undergoing ovarian stimulation is increased after unilateral oophorectomy.
    Grynberg M; Pytel S; Peigne M; Sonigo C
    Hum Reprod; 2023 Jun; 38(6):1162-1167. PubMed ID: 36961937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome.
    Gallot V; Berwanger da Silva AL; Genro V; Grynberg M; Frydman N; Fanchin R
    Hum Reprod; 2012 Apr; 27(4):1066-72. PubMed ID: 22279090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.
    Fanchin R; Schonäuer LM; Righini C; Frydman N; Frydman R; Taieb J
    Hum Reprod; 2003 Feb; 18(2):328-32. PubMed ID: 12571169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
    Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
    J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation.
    Fanchin R; Méndez Lozano DH; Louafi N; Achour-Frydman N; Frydman R; Taieb J
    Hum Reprod; 2005 Mar; 20(3):747-51. PubMed ID: 15618255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
    Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates.
    Xu J; Bishop CV; Lawson MS; Park BS; Xu F
    Hum Reprod; 2016 Jul; 31(7):1522-30. PubMed ID: 27165618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT).
    Genro VK; Matte U; De Conto E; Cunha-Filho JS; Fanchin R
    J Assist Reprod Genet; 2012 Jul; 29(7):657-63. PubMed ID: 22527896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.
    Dumesic DA; Lesnick TG; Stassart JP; Ball GD; Wong A; Abbott DH
    Fertil Steril; 2009 Jul; 92(1):217-21. PubMed ID: 18675414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status.
    Fanchin R; Louafi N; Méndez Lozano DH; Frydman N; Frydman R; Taieb J
    Fertil Steril; 2005 Jul; 84(1):167-73. PubMed ID: 16009173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].
    He Y; Xia R; Chen X; Ye D; Tang Y; Li P; Niu J; Chen S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):216-20. PubMed ID: 23443775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early follicle development during the luteal-follicular transition affects the predictability of serum follicle-stimulating hormone but not antimüllerian hormone levels on cycle day 3.
    Grynberg M; Genro V; Gallot V; El-Ali A; Frydman R; Fanchin R
    Fertil Steril; 2010 Oct; 94(5):1827-31. PubMed ID: 19878941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.